跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Olanzgrand 5 - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Olanzgrand 5
Approved
STANDARD
Olanzgrand 5
Ravian Life Science Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
bdaabefc982d6de5
Company
Ravian Life Science Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
bdaabefc982d6de5
Drug Approval Philippines Name
Olanzgrand 5
Product Name
Olanzgrand 5
Registration Number
DRP-5463-03
Brand Name
Olanzgrand 5
Generic Name
Olanzapine
Dosage Form
Orodispersible Tablet
Dosage Strength
5 mg
Manufacturer
Ravian Life Science Pvt. Ltd.
Importer
Pharmakon Biotec Inc.
Distributor
Grandis Pharma Incorporated
Issuance Date
28 August 2024
Expiry Date
18 August 2029
Pharmacologic Category
Antipsychotic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
bdaabefc982d6de5
Type
Standard
Back to Philippines FDA Approvals